Literature DB >> 16282411

Methods to assess the costs and health effects of interventions for improving health in developing countries.

David B Evans1, Tessa Tan-Torres Edejer, Taghreed Adam, Stephen S Lim.   

Abstract

Mesh：

Year:  2005        PMID： 16282411      PMCID： PMC1283282          DOI： 10.1136/bmj.331.7525.1137

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  18 in total

1.  Accounting for the cost of scaling-up health interventions.

Authors:  Benjamin Johns; Rob Baltussen
Journal:  Health Econ       Date:  2004-11       Impact factor: 3.046

2.  Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.

Authors:  Karl Claxton; Mark Sculpher; Chris McCabe; Andrew Briggs; Ron Akehurst; Martin Buxton; John Brazier; Tony O'Hagan
Journal:  Health Econ       Date:  2005-04       Impact factor: 3.046

Review 3.  Time to reassess strategies for improving health in developing countries.

Authors:  David B Evans; Taghreed Adam; Tessa Tan-Torres Edejer; Stephen S Lim; Andrew Cassels; Timothy G Evans
Journal:  BMJ       Date:  2005-11-12

4.  Five-hundred life-saving interventions and their cost-effectiveness.

Authors:  T O Tengs; M E Adams; J S Pliskin; D G Safran; J E Siegel; M C Weinstein; J D Graham
Journal:  Risk Anal       Date:  1995-06       Impact factor: 4.000

5.  The global burden of disease in 1990: summary results, sensitivity analysis and future directions.

Authors:  C J Murray; A D Lopez; D T Jamison
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

6.  Cost effectiveness analysis of strategies for child health in developing countries.

Authors:  Tessa Tan-Torres Edejer; Moses Aikins; Robert Black; Lara Wolfson; Raymond Hutubessy; David B Evans
Journal:  BMJ       Date:  2005-11-10

7.  Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries.

Authors:  Daniel R Hogan; Rob Baltussen; Chika Hayashi; Jeremy A Lauer; Joshua A Salomon
Journal:  BMJ       Date:  2005-11-10

8.  Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?

Authors:  Juan Pablo Gutierrez; Benjamin Johns; Taghreed Adam; Stefano M Bertozzi; Tessa Tan-Torres Edejer; Robert Greener; Catherine Hankins; David B Evans
Journal:  Lancet       Date:  2004 Jul 3-9       Impact factor: 79.321

9.  Enhancing the comparability of costing methods: cross-country variability in the prices of non-traded inputs to health programmes.

Authors:  Benjamin Johns; Taghreed Adam; David B Evans
Journal:  Cost Eff Resour Alloc       Date:  2006-04-24

10.  Programme costs in the economic evaluation of health interventions.

Authors:  Benjamin Johns; Rob Baltussen; Raymond Hutubessy
Journal:  Cost Eff Resour Alloc       Date:  2003-02-26
View more
  57 in total

1.  Cost effectiveness analysis of strategies for tuberculosis control in developing countries.

Authors:  Rob Baltussen; Katherine Floyd; Christopher Dye
Journal:  BMJ       Date:  2005-11-10

Review 2.  Time to reassess strategies for improving health in developing countries.

Authors:  David B Evans; Taghreed Adam; Tessa Tan-Torres Edejer; Stephen S Lim; Andrew Cassels; Timothy G Evans
Journal:  BMJ       Date:  2005-11-12

3.  Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries.

Authors:  Taghreed Adam; Stephen S Lim; Sumi Mehta; Zulfiqar A Bhutta; Helga Fogstad; Matthews Mathai; Jelka Zupan; Gary L Darmstadt
Journal:  BMJ       Date:  2005-11-12

Review 4.  Evaluation of current strategies and future priorities for improving health in developing countries.

Authors:  David B Evans; Stephen S Lim; Taghreed Adam; Tessa Tan-Torres Edejer
Journal:  BMJ       Date:  2005-11-10

Review 5.  Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches.

Authors:  Sun-Young Kim; Sue J Goldie
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

6.  Requisite models for strategic commissioning: the example of type 1 diabetes.

Authors:  Mara Airoldi; Gwyn Bevan; Alec Morton; Mónica Oliveira; Jenifer Smith
Journal:  Health Care Manag Sci       Date:  2008-06

Review 7.  Cost-effectiveness analysis and HIV screening: the emergency medicine perspective.

Authors:  Heather Hsu; Rochelle P Walensky
Journal:  Ann Emerg Med       Date:  2011-07       Impact factor: 5.721

8.  Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis.

Authors:  Dan Chisholm; Oye Gureje; Sandra Saldivia; Marcelo Villalón Calderón; Rajitha Wickremasinghe; Nalaka Mendis; Jose-Luis Ayuso-Mateos; Shekhar Saxena
Journal:  Bull World Health Organ       Date:  2008-07       Impact factor: 9.408

9.  Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South Africa.

Authors:  Carel Pretorius; John Stover; Lori Bollinger; Nicolas Bacaër; Brian Williams
Journal:  PLoS One       Date:  2010-11-05       Impact factor: 3.240

10.  The use of cost-effectiveness analysis for pediatric immunization in developing countries.

Authors:  Cindy Low Gauvreau; Wendy J Ungar; Jillian Clare Köhler; Stanley Zlotkin
Journal:  Milbank Q       Date:  2012-12       Impact factor: 4.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.